96 related articles for article (PubMed ID: 8179977)
1. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease.
Paydas S; Aksu HS; Paydas S; Burgut R; Sagliker Y
Br J Clin Pract; 1994; 48(1):25-6. PubMed ID: 8179977
[TBL] [Abstract][Full Text] [Related]
2. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis and HIV infection during haemodialysis.
Saha D; Agarwal SK
J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco].
Sekkat S; Kamal N; Benali B; Fellah H; Amazian K; Bourquia A; El Kholti A; Benslimane A
Nephrol Ther; 2008 Apr; 4(2):105-10. PubMed ID: 18272446
[TBL] [Abstract][Full Text] [Related]
11. Patient to patient transmission of hepatitis C virus in hemodialysis units.
Taskapan H; Oymak O; Dogukan A; Utas C
Clin Nephrol; 2001 Jun; 55(6):477-81. PubMed ID: 11434360
[TBL] [Abstract][Full Text] [Related]
12. [The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients].
Motta M; Brischetto R; Rapisarda F; Corno C; Rapisarda C; Fatuzzo P; Messina A; Biondi A; Mezzasalma E; Calcara G
Ann Ital Med Int; 1991; 6(4):375-8. PubMed ID: 1666516
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca].
Boulaajaj K; Elomari Y; Elmaliki B; Madkouri B; Zaid D; Benchemsi N
Nephrol Ther; 2005 Nov; 1(5):274-84. PubMed ID: 16895696
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients.
Dentico P; Sacco R; Buongiorno R; Volpe A; Ranieri C; Carbone M; Carabellese S
Microbios; 1999; 99(392):55-62. PubMed ID: 10624011
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and significance of hepatitis C virus (HCV) genotypes in anti-HCV positive patients in northwest Croatia.
Golubić D; Vurusić B; Kessler HH
Acta Med Croatica; 1997; 51(2):79-82. PubMed ID: 9204591
[TBL] [Abstract][Full Text] [Related]
17. [Viral hepatitis C in chronic hemodialyzed patients in southern Tunisia. Prevalence and risk factors].
Hachicha J; Hammami A; Masmoudi H; Ben Hmida M; Karray H; Kharrat M; Kammoun F; Jarraya A
Ann Med Interne (Paris); 1995; 146(5):295-8. PubMed ID: 8526312
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia.
Vardas E; Sitas F; Seidel K; Casteling A; Sim J
Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
